JUL 06, 2016 04:38 AM PDT

Cancer and Addiction May Share a Common Drug

Researchers from the University of London have found that a drug used to combat addiction may also be effective at killing cancer cells. The discovery has wide implications for cancer treatment, given that the drug of interest is naltrexone, a drug widely prescribed for addicts.
Drug that helps addicts may help treat cancer too | Image: pixabay.com

Finding new uses for an old drug is a noteworthy endeavor. If the drug is already approved for use in another capacity, researchers can significantly shorten the time it takes before the drug can be prescribed to patients for new applicable uses. Thus the team at St. George’s, University of London, are quite hopeful the discovery will expedite future clinical trials for cancer treatment.
In studying the effects of naltrexone on cancer cells, the team observed that the cells stopped growing. They also reported naltrexone altered the cells’ internal working mechanisms, causing certain genes to be turned on at higher intensity. This ultimately led to the cells killing themselves more readily, thus reducing the cancer growth.
"Rather than stopping the cancer cells from growing, patients want to be rid of them. We saw that by giving the drug for two days, then withdrawing it, cancer cells would stop cycling and undergo cell death," said Wai Liu, first study author.
Through further investigation, the team found that naltrexone selectively affected genes involved in regulating the cell cycle and the immune system. Genes that are involved with programmed cell death were also triggered by naltrexone, implicating a mechanism for the increased deaths of the cancer cells.
"We have shown that the genetic fingerprint of naltrexone differs according to the different doses used, which identifies new ways of using it as an anti-cancer treatment,” said Liu. The doses used in the study are much lower than what’s used in treating addiction.

 Naltrexone is commonly used to treat alcoholism. And as an opioid antagonist, this drug is also used to treat opioid addiction. At high doses, there’s a risk for liver damage and gastrointestinal problems.
And because the drug is already approved and on the market, it becomes that much more attractive. Liu, who has been researching cancer treatments for over two decades, hopes clinical trials will lead to naltrexone use in conjunction with other anticancer treatments. "We have taken a drug that is relatively safe in humans, and reformulated a new use for it; this has only been possible by understanding the dynamics of a drug. How many other drugs can be improved in this way?” asked Liu.

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 25, 2018
JUL 25, 2018
Can CT Scans Increase the Risk of Brain Cancer?
Medical imaging has gone from fuzzy X-rays that didn't show much, to real-time functional MRI scans in just a few decades. Being able to see inside the...
JUL 26, 2018
Genetics & Genomics
JUL 26, 2018
When a Cancer Gene Switches Sides
All cells carry a gene named p53, which has a vital role in shielding the body from cancer. But it can betray cells too....
AUG 14, 2018
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
SEP 01, 2018
SEP 01, 2018
How eating vegetables can help prevent colon cancer?
We have always been told to eat more vegetables as they are rich in many nutrients and vitamins as well as the ability to protect us from many diseases. Re...
NOV 05, 2018
NOV 05, 2018
How UV Rays Cause Aging and Skin Cancer
We know that UV rays can do damage to our DNA - but how?...
DEC 04, 2018
Drug Discovery
DEC 04, 2018
Drug Combination May Be Effective for Melanoma
Protein kinase inhibitors have been noted to be the most effective class of drugs in the treatment of melanoma—a deadly skin cancer of the melanocyte...
Loading Comments...